Antibe Therapeutics Inc. current ratio

The Current Ratio as of November 2026 (TTM) for Antibe Therapeutics Inc. (ATBPF) is 15.03

According to Antibe Therapeutics Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 15.03. This represents a change of 35.09% compared to the average of 11.13 of the last 4 quarters.

Antibe Therapeutics Inc. (ATBPF) Historical Current Ratio (quarterly & annually)

How has ATBPF Current Ratio performed in the past?

The mean historical Current Ratio of Antibe Therapeutics Inc. over the last ten years is 6.63. The current 15.03 Current Ratio has changed 126.75% with respect to the historical average. Over the past ten years (40 quarters), ATBPF's Current Ratio was at its highest in in the June 2021 quarter at 21.59. The Current Ratio was at its lowest in in the December 2017 quarter at 1.01.

Antibe Therapeutics Inc. (ATBPF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Antibe Therapeutics Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Antibe Therapeutics Inc. (ATBPF) Average Current Ratio

How has ATBPF Current Ratio performed in the past?

The current Current Ratio of Antibe Therapeutics Inc. (ATBPF) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Antibe Therapeutics Inc. (ATBPF) Current Ratio vs. Peers

How is ATBPF’s Current Ratio compared to its peers?

Antibe Therapeutics Inc.’s Current Ratio is less than LexaGene Holdings Inc. (0), greater than Titan Medical Inc. (2.78), greater than Verici Dx plc (2.82), less than RIV Capital Inc. (83.68), greater than Eiger BioPharmaceuticals, Inc. (0.71), less than Living Cell Technologies Limited (17.89), greater than Progressive Care, Inc. (1.72), greater than MGC Pharmaceuticals Limited (0.19), less than Nuvo Pharmaceuticals Inc. (0), greater than Cloud DX Inc. (0.06),

Build a custom stock screener for Antibe Therapeutics Inc. (ATBPF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Antibe Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Antibe Therapeutics Inc. (ATBPF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Antibe Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.